AU2001272948A1 - Hcv antigen/antibody combination assay - Google Patents

Hcv antigen/antibody combination assay

Info

Publication number
AU2001272948A1
AU2001272948A1 AU2001272948A AU7294801A AU2001272948A1 AU 2001272948 A1 AU2001272948 A1 AU 2001272948A1 AU 2001272948 A AU2001272948 A AU 2001272948A AU 7294801 A AU7294801 A AU 7294801A AU 2001272948 A1 AU2001272948 A1 AU 2001272948A1
Authority
AU
Australia
Prior art keywords
hcv
antigens
antigen
antibody combination
hcv antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272948A
Inventor
Phillip Arcangel
David Y Chien
Doris Coit
Carlos George-Nasciemento
Angelica Medina-Selby
Laura Tandeske
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27395684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001272948(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU2001272948A1 publication Critical patent/AU2001272948A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Abstract

The invention relates to a method of detecting HCV infection in a biological sample, the method comprising providing an immunoassay solid support, comprising an HCV anti-core antibody, an antigen comprising an HCV NS3/4a epitope, and an HCV multiple epitope fusion antigen, that can detect both HCV antigens and antibodies present in a sample. The invention also includes polynucleotides encoding multiple epitope fusion antigens for use in the assay, recombinant vectors and host cells comprising such polynucleotides, and methods of producing the multiple epitope fusion antigens.
AU2001272948A 2000-06-15 2001-06-14 Hcv antigen/antibody combination assay Abandoned AU2001272948A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US21208200P 2000-06-15 2000-06-15
US60/212,082 2000-06-15
US28081101P 2001-04-02 2001-04-02
US28086701P 2001-04-02 2001-04-02
US60/280,811 2001-04-02
US60/280,867 2001-04-02
PCT/US2001/019369 WO2001096875A2 (en) 2000-06-15 2001-06-14 Hcv antigen/antibody combination assay

Publications (1)

Publication Number Publication Date
AU2001272948A1 true AU2001272948A1 (en) 2001-12-24

Family

ID=27395684

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001272945A Abandoned AU2001272945A1 (en) 2000-06-15 2001-06-14 Immunoassays for anti-hcv antibodies
AU2001272948A Abandoned AU2001272948A1 (en) 2000-06-15 2001-06-14 Hcv antigen/antibody combination assay

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001272945A Abandoned AU2001272945A1 (en) 2000-06-15 2001-06-14 Immunoassays for anti-hcv antibodies

Country Status (23)

Country Link
US (5) US6630298B2 (en)
EP (2) EP1354204B2 (en)
JP (3) JP4837229B2 (en)
CN (3) CN100463922C (en)
AT (2) ATE368221T1 (en)
AU (2) AU2001272945A1 (en)
BG (1) BG66205B1 (en)
BR (2) BRPI0111682B8 (en)
CA (2) CA2412035C (en)
CY (2) CY1107537T1 (en)
CZ (1) CZ304185B6 (en)
DE (2) DE60125240T3 (en)
DK (2) DK1350105T3 (en)
ES (2) ES2288969T3 (en)
HK (2) HK1061861A1 (en)
HU (1) HU228873B1 (en)
MX (2) MXPA02012401A (en)
NO (1) NO332275B1 (en)
PL (1) PL213363B1 (en)
PT (2) PT1354204E (en)
SI (1) SI1354204T2 (en)
SK (1) SK287694B6 (en)
WO (2) WO2001096870A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433160T2 (en) * 1993-05-12 2004-07-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Preserved motif of the hepatitis C virus E2 / NS1 region
US7491808B2 (en) * 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
PT1354204E (en) * 2000-06-15 2007-03-30 Novartis Vaccines & Diagnostic Hcv antigen/antibody combination assay
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6960569B2 (en) 2000-08-17 2005-11-01 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
DE10106295C1 (en) * 2001-02-02 2002-08-22 Gaifar German American Inst Fo Protein with multiple antigen-epitope sequences, which is immobilized
AR033448A1 (en) * 2001-03-28 2003-12-17 Ortho Clinical Diagnostics Inc ANTIGEN-ANTIBODY COMBINATION TEST FOR HEPATITIS C FOR AN EARLY DETECTION OF INFECTION
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
WO2003002749A2 (en) * 2001-06-26 2003-01-09 Abbott Laboratories Methods for the simultaneous detection of hcv antigens and hcv antibodies
US7049060B2 (en) * 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (en) 2002-05-10 2007-07-27 Bio Rad Pasteur METHOD FOR THE SIMULTANEOUS DETECTION OF ANTIGEN AND ANTIBODY OF AN INFECTIOUS MICROORGANISM
WO2004021871A2 (en) * 2002-09-09 2004-03-18 Chiron Corporation Hcv assay
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
WO2005019828A1 (en) 2003-08-20 2005-03-03 Amorfix Life Sciences Ltd. Epitope protection assay and method for detecting protein conformations
ATE542140T1 (en) * 2004-08-27 2012-02-15 Novartis Vaccines & Diagnostic NON-STRUCTURAL HCV PROTEIN MUTANTS AND POSSIBLE USES THEREOF
WO2006081701A1 (en) * 2005-02-02 2006-08-10 Peng Cui A kit for detecting the antibody of hcv and its preparing method
CA2630220C (en) 2005-11-22 2020-10-13 Doris Coit Norovirus and sapovirus antigens
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
US7794692B2 (en) * 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
EP1989308B1 (en) 2006-03-03 2017-05-31 ProMIS Neurosciences Inc. Methods and compositions to treat and detect misfolded-sod1 mediated diseases
CN1908666B (en) * 2006-08-14 2010-05-12 武汉大学 Enzyme linked immunity diagnose reagent kit for HB core antigen detecting in two sandwich method and application thereof
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
ES2497016T3 (en) * 2009-03-30 2014-09-22 bioMérieux Solid HCV detection support
US20100297607A1 (en) * 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
EP2556151A1 (en) 2010-04-07 2013-02-13 Novartis AG Method for generating a parvovirus b19 virus-like particle
EP2583101B1 (en) * 2010-06-17 2015-09-16 Koninklijke Philips N.V. Multi epitope assay
WO2012006293A1 (en) 2010-07-06 2012-01-12 Novartis Ag Norovirus derived immunogenic compositions and methods
WO2012006500A2 (en) * 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
CN108085330A (en) * 2011-01-13 2018-05-29 奥索临床诊断有限公司 treponema pallidum triplet antigen
FR2984328B1 (en) 2011-12-20 2016-12-30 Bio-Rad Innovations METHOD FOR DETECTING HEPATITIS C VIRUS INFECTION
CA2906421C (en) 2013-03-14 2022-08-16 George J. Dawson Hcv antigen-antibody combination assay and methods and compositions for use therein
MX2015012825A (en) 2013-03-14 2016-06-10 Abbott Lab Hcv core lipid binding domain monoclonal antibodies.
BR112015023355A8 (en) 2013-03-14 2018-01-30 Abbott Lab hcv ns3 recombinant antigens and mutants thereof for enhanced antibody detection.
CN103630690B (en) * 2013-12-17 2014-08-20 朱之炜 Hepatitis C virus antigen-antibody combined detection kit and detection method
WO2016160046A1 (en) 2015-03-27 2016-10-06 Ortho-Clinical Diagnostics, Inc. Hcv ns4a/modified ns3 polypeptides and uses thereof
EP3285806A4 (en) * 2015-04-20 2019-03-27 Qoolabs, Inc. Camelid single-domain hcv antibodies and methods of use
CN111164221B (en) * 2017-09-27 2024-03-29 生物辐射实验室股份有限公司 Digital affinity ligation assay
CN110261616B (en) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 Hepatitis C virus detection kit
CN115838420B (en) * 2022-10-31 2023-05-05 北京科跃中楷生物技术有限公司 Preparation method of soluble HCV recombinant protein and antibody detection reagent prepared by preparation method

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
YU48038B (en) * 1987-11-18 1996-10-18 Chiron Corp. PROCEDURE FOR DIAGNOSIS OF NO-A, NO-V HEPATITIS
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
BR8807310A (en) * 1987-11-18 1990-03-13 Chiron Corp POLINUCLEOTIDIO, POLINUCLEOTIDIO RECOMBINANT, RECOMBINANT VECTOR, CELL HOSTESS, EXPRESSION SYSTEM RECOMBINANT, CELL TRANSFORMED, polypeptide, HCV, DE polypeptide PREPARATION, polypeptide OF HCV polypeptide PURIFIED, polypeptide RECOMBINANT, DE FUSION polypeptide, MONOCLONAL ANTIBODY, PREPARATION PURIFIED ANTIBODY POLYCLONAL, PARTICLE, POLYNUCLEOTID PROBE, ANTIBODY KIT FOR HCV EPETOPE, METHOD FOR POLYPEPTIDY PRODUCTION, METHOD FOR DETECTING HCV NUCLEIC ACIDS, IMMUNOENSAIO TO DETECT HCV ANTIGENE, IMMUNOENSAIO DETECTORIGIO ANTIGENE OF HCV, CELL, CELL INFECTED WITH HCV, METHOD FOR THE PRODUCTION OF ANTIBODIES FOR HCV AND METHOD FOR ISOLATING CDNA DERIVED FROM THE GENOME FROM AN UNIDENTIFIED INFECTIOUS AGENT
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
JP2730153B2 (en) 1989-03-16 1998-03-25 日本合成ゴム株式会社 Thermoplastic resin composition and method for producing the same
JP2656995B2 (en) * 1989-03-17 1997-09-24 カイロン コーポレイション NANBV diagnostics
AU638719B2 (en) * 1989-05-18 1993-07-08 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
US6312889B1 (en) 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
WO1991015771A1 (en) * 1990-04-04 1991-10-17 Chiron Corporation Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
PT97247B (en) * 1991-04-03 1997-10-31 Chiron Corp PREPARATION PROCESS OF ANTIGEN COMBINATIONS OF HEPAPITE C VIRUS (HCV) FOR USE IN IMMUNOSENSES FOR ANTI-HCV ANTIBODIES
RU2148587C1 (en) 1991-06-24 2000-05-10 Чирон Корпорейшн Polypeptide and method of its synthesis, reagent for immuno-analysis, method of assay of antibody presence, method of induction of immune response
UA39944C2 (en) * 1992-07-07 2001-07-16 Чірон Корпорейшн METHOD FOR DETERMINATION OF EARLY SEROCONVERSION IN MAMMAL-TO-MACHINE TO HEPATITIS C VIRUS AND KIT FOR USE IN THE METHOD
AU688323B2 (en) * 1993-04-27 1998-03-12 N.V. Innogenetics S.A. New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
JP3217600B2 (en) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 Immunoassay for non-A non-B hepatitis virus-related antigen, monoclonal antibody used therein, and hybridoma producing this antibody
DE4428705A1 (en) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Recombinant antigen from the NS3 region of the hepatitis C virus
US5843752A (en) 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
CA2250723C (en) * 1996-05-24 2012-07-17 Chiron Corporation Multiple epitope fusion protein
US6322965B1 (en) * 1997-02-10 2001-11-27 Advanced Life Science Institute, Inc. Chimera antigen peptide
US6391540B1 (en) * 1997-09-22 2002-05-21 Chiron Corporation Method for detecting antibodies in a sample
CN1274424A (en) * 1998-07-30 2000-11-22 株式会社先端生命科学研究所 Method for assaying hepatitis C virus
PT1354204E (en) * 2000-06-15 2007-03-30 Novartis Vaccines & Diagnostic Hcv antigen/antibody combination assay

Also Published As

Publication number Publication date
DE60129598T2 (en) 2008-04-17
US20040096822A1 (en) 2004-05-20
WO2001096875A3 (en) 2003-08-28
HUP0500444A3 (en) 2010-03-29
US6630298B2 (en) 2003-10-07
ATE368221T1 (en) 2007-08-15
CN1256591C (en) 2006-05-17
EP1350105A2 (en) 2003-10-08
BRPI0111682B8 (en) 2021-07-27
CY1106820T1 (en) 2012-05-23
US6797809B2 (en) 2004-09-28
US20040265801A1 (en) 2004-12-30
CA2413003A1 (en) 2001-12-20
WO2001096875A2 (en) 2001-12-20
CZ304185B6 (en) 2013-12-11
US6632601B2 (en) 2003-10-14
MXPA02012401A (en) 2003-04-25
SI1354204T2 (en) 2010-09-30
EP1354204B1 (en) 2006-12-13
HU228873B1 (en) 2013-06-28
WO2001096870A3 (en) 2003-07-31
EP1350105B1 (en) 2007-07-25
ES2288969T3 (en) 2008-02-01
SK287694B6 (en) 2011-06-06
HUP0500444A2 (en) 2005-08-29
WO2001096870A2 (en) 2001-12-20
ATE348337T1 (en) 2007-01-15
BR0111731A (en) 2004-02-10
CN1214244C (en) 2005-08-10
US7241879B2 (en) 2007-07-10
BRPI0111731B1 (en) 2016-07-05
CN1489692A (en) 2004-04-14
US20020146685A1 (en) 2002-10-10
DK1350105T3 (en) 2007-11-12
US7319144B2 (en) 2008-01-15
HK1061861A1 (en) 2004-10-08
CN1660913A (en) 2005-08-31
BG66205B1 (en) 2012-01-31
CY1107537T1 (en) 2013-03-13
CN100463922C (en) 2009-02-25
DK1354204T4 (en) 2010-06-14
BR0111682A (en) 2004-01-06
ES2277932T3 (en) 2007-08-01
DE60129598D1 (en) 2007-09-06
SK17772002A3 (en) 2003-10-07
MXPA02012424A (en) 2003-04-25
CA2413003C (en) 2013-08-13
NO20025878D0 (en) 2002-12-06
PT1354204E (en) 2007-03-30
CA2412035A1 (en) 2001-12-20
BRPI0111731C1 (en) 2021-07-27
JP2004506878A (en) 2004-03-04
JP4834279B2 (en) 2011-12-14
PT1350105E (en) 2007-08-13
EP1354204B2 (en) 2010-04-21
DE60125240T3 (en) 2010-10-28
EP1354204A2 (en) 2003-10-22
CA2412035C (en) 2012-04-10
US20020192639A1 (en) 2002-12-19
AU2001272945A1 (en) 2001-12-24
DE60125240T2 (en) 2007-07-12
PL365599A1 (en) 2005-01-10
CZ20024058A3 (en) 2003-09-17
US20040063092A1 (en) 2004-04-01
DE60125240D1 (en) 2007-01-25
WO2001096875A9 (en) 2002-08-15
BRPI0111731B8 (en) 2016-08-23
ES2277932T5 (en) 2010-06-28
SI1354204T1 (en) 2007-04-30
JP2011125350A (en) 2011-06-30
HK1079796A1 (en) 2006-04-13
CN1466682A (en) 2004-01-07
NO20025878L (en) 2003-02-12
JP2004510133A (en) 2004-04-02
DK1354204T3 (en) 2007-04-10
PL213363B1 (en) 2013-02-28
JP4837229B2 (en) 2011-12-14
BG107441A (en) 2004-01-30
BRPI0111682B1 (en) 2017-09-19
NO332275B1 (en) 2012-08-13

Similar Documents

Publication Publication Date Title
AU2001272948A1 (en) Hcv antigen/antibody combination assay
HK1045729A1 (en) Early detection of flavivviruses using the ns1 glycoprotein.
NO20051715L (en) HCV assay
WO2002090961A3 (en) Systems and methods for detection of analytes in biological fluids
WO2003095968A3 (en) Method for simultaneously detecting an antigen and an antibody of an infectious microorganism
WO2001066568A3 (en) Use of recombinant antigens to determine the immune status of an animal
US6723502B2 (en) Hepatitis C antigen—antibody combination assay for the early detection of infection
CA2071016A1 (en) Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto
WO2003012395A3 (en) Early detection of mycobacterial disease using peptides
EP1310796A3 (en) Reagents for the simultaneous detection of HCV core antigens and antibodies
AU6688700A (en) Diagnostic assay for human matrix gla-protein and its use as a biomarker
WO2001009609A3 (en) Hepatitis c viral antigen immunoassay detection systems
EP0985931A3 (en) Recombinant antigen immunoassay for the diagnosis of syphilis
Ireland Development of enzyme-linked immunosorbent assays for antibodies to hepatitis B virus.
AR037215A1 (en) REAGENTS FOR THE SIMULTANEOUS DETECTION OF ANTIBODIES AND NUCLEAR ANTIGENS OF HCV